Foley Secures Rare Inter Partes Review Wins for Patent Owner Supernus Pharmaceuticals
10 December 2014
Foley secured three significant inter partes review victories on behalf of Supernus Pharmaceuticals, Inc. and Galderma S.A. for a pharmaceutical product, which represents one of the first inter partes reviews to reach a final decision in favor of the patent owner, where the patents were the subject of a parallel Hatch-Waxman patent litigation. The inter partes reviews were filed by a “generic” company that filed an Abbreviated New Drug application to market a generic version of the product Oracea®.
The Foley team, led by Stephen Maebius, included Andrew Baluch, George Quillin, and Sunit Talapatra.
People
Related News
15 April 2024
Press Releases
Foley Names Andrew Wronski as Manufacturing Sector Chair
Foley & Lardner LLP is pleased to announce that Andrew “Andy” Wronski has been named chair of the firm’s Manufacturing Sector, effective April 15, 2024.
03 April 2024
Press Releases
Foley Continues East Coast Growth with Transactions Partner Joe Bernardi, Strengthening Capabilities in the Technology Sector
Foley & Lardner LLP announced today that the firm has bolstered its Innovative Technology Sector and Private Equity and M&A Practices with the addition of partner Joe Bernardi in Boston.
01 April 2024
Press Releases
Foley Adds Former DOJ Assistant Chief Mark Grundvig to Antitrust Team
Foley & Lardner LLP announced today that Mark Grundvig has joined the firm’s Antitrust & Competition Practice Group as a partner in its Washington, D.C. office.